^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PARP1 underexpression

    i
    Other names: PARP1, Poly(ADP-Ribose) Polymerase 1, ADP-Ribosyltransferase (NAD+; Poly (ADP-Ribose) Polymerase), ADP-Ribosyltransferase Diphtheria Toxin-Like 1, Poly (ADP-Ribose) Polymerase Family, Member 1, Protein Poly-ADP-Ribosyltransferase PARP1, DNA ADP-Ribosyltransferase PARP1, NAD(+) ADP-Ribosyltransferase 1, Poly [ADP-Ribose] Polymerase 1, Poly[ADP-Ribose] Synthase 1, ADPRT 1, PARP-1, ADPRT, ARTD1, PPOL, ADP-Ribosyltransferase NAD(+), Poly(ADP-Ribosyl)Transferase, Poly(ADP-Ribose) Synthetase, PADPRT-1, ADPRT1, PARP
    Entrez ID:
    142
    Related biomarkers:
    Expression
    Mutation
    Others
    2years
    Identification of ATR inhibitors as therapeutic opportunities in Desmoplastic small round cell tumors (AACR 2022)
    DSRCT cells are sensitive to ATR and PARP inhibitors, through a mechanism that, at least in part, may involve enhanced replication stress and increased R-loop formation. Our data provide the preclinical rationale for assessing ATRi combined with PARPi in patients with DSRCT, as a cytotoxic therapy or as an immunomodulatory approach to enhance cell-autonomous immunogenicity.
    PARP Biomarker • PD(L)-1 Biomarker • IO biomarker
    |
    PD-L1 (Programmed death ligand 1) • WT1 (WT1 Transcription Factor) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • RAD51 (RAD51 Homolog A) • EWSR1 (EWS RNA Binding Protein 1) • STING (stimulator of interferon response cGAMP interactor 1) • CCL5 (Chemokine (C-C motif) ligand 5)
    |
    PARP1 underexpression